Shoulder Competitors

Stocks . USA . 
Stock . Shoulder Innovations
SI Stock  USD 13.05  0.01  0.08%   
Shoulder Innovations competes with Inogen, SANUWAVE Health,, MDxHealth, Outset Medical, and Aardvark Therapeutics; as well as few others. The company is active under Health Care Equipment & Supplies sector as part of Health Care industry. Analyzing Shoulder Innovations competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Shoulder Innovations to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Shoulder Innovations Correlation with its peers.
For more detail on how to invest in Shoulder Stock please use our How to Invest in Shoulder Innovations guide.

Shoulder Innovations vs Nautilus Biotechnology Correlation

Very good diversification

The correlation between Shoulder Innovations and NAUT is -0.26 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Shoulder Innovations and NAUT in the same portfolio, assuming nothing else is changed.

Moving together with Shoulder Stock

  0.63IL3 Integra LifeSciences Earnings Call Next WeekPairCorr
  0.81EW Edwards Lifesciences CorpPairCorr

Moving against Shoulder Stock

  0.79HYB HOYAPairCorr
  0.71EDAP EDAP TMS SAPairCorr
  0.57VREX Varex Imaging CorpPairCorr
  0.53EKSO Ekso Bionics Holdings TrendingPairCorr
  0.41SKAN SKAN Group AGPairCorr
The current Return On Tangible Assets is estimated to decrease to -0.44. The current Return On Capital Employed is estimated to decrease to -0.5. The Shoulder Innovations' current Intangibles To Total Assets is estimated to increase to 0.01, while Return On Tangible Assets are projected to decrease to (0.44).
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
9.2313.0616.89
Details
Intrinsic
Valuation
LowRealHigh
7.6711.5015.33
Details
Naive
Forecast
LowNextHigh
9.1412.9616.79
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.34-0.34-0.34
Details

Shoulder Innovations Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Shoulder Innovations and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Shoulder and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Shoulder Innovations does not affect the price movement of the other competitor.

High positive correlations

ASMB
+ 0.89
SNWV
SNWV
+ 0.87
INGN
ASMB
+ 0.86
INGN
NNOX
+ 0.73
SNWV
ASMB
+ 0.69
NNOX
NNOX
+ 0.66
INGN
  

High negative correlations

ASMB
- 0.87
EPRX
EPRX
- 0.84
SNWV
EPRX
- 0.75
INGN
ENTA
- 0.74
OM
EPRX
- 0.65
NNOX
NNOX
- 0.43
AARD

Risk-Adjusted Indicators

There is a big difference between Shoulder Stock performing well and Shoulder Innovations Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Shoulder Innovations' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
INGN  1.91 (0.29) 0.00 (0.37) 0.00 
 0.00 
 4.40 
(3.26)
 19.47 
SNWV  1.84 (0.59) 0.00 (0.93) 0.00 
 0.00 
 3.73 
(4.26)
 12.41 
MDXH  2.88  0.23  0.07  0.32  3.10 
(3.47)
 6.96 
(4.56)
 17.05 
OM  4.62 (0.60) 0.00 (0.23) 0.00 
 0.00 
 9.51 
(10.79)
 38.45 
AARD  3.60  0.54  0.14  0.26  3.69 
(3.96)
 9.35 
(6.45)
 38.95 
NNOX  4.00 (0.30) 0.00 (0.15) 0.00 
 0.00 
 9.44 
(6.31)
 36.87 
EPRX  2.80  0.37  0.13  0.77  2.55 
(3.46)
 6.71 
(4.46)
 24.61 
ASMB  2.88 (0.30) 0.00 (0.26) 0.00 
 0.00 
 5.85 
(6.65)
 18.53 
ENTA  2.47  0.25  0.07  0.67  2.69 
(2.58)
 5.67 
(3.78)
 15.79 
NAUT  4.56  0.94  0.17 (1.06) 4.34 
(5.89)
 9.85 
(7.62)
 28.35 

Shoulder Innovations Competitive Analysis

The better you understand Shoulder Innovations competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Shoulder Innovations' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Shoulder Innovations' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SI INGN SNWV MDXH OM AARD NNOX EPRX ASMB ENTA
 0.08 
 13.05 
Shoulder
 2.46 
 5.83 
Inogen
 3.90 
 23.92 
SANUWAVE
 3.24 
 3.51 
MDxHealth
 6.77 
 3.47 
Outset
 1.61 
 12.65 
Aardvark
 1.74 
 2.34 
Nano
 0.85 
 8.16 
Eupraxia
 3.85 
 28.89 
Assembly
 0.22 
 13.89 
Enanta
Market Volatility
(90 Days Market Risk)
Somewhat reliable
Somewhat reliable
Very steady
Relatively risky
Unstable
Somewhat reliable
Dangerous
Slightly risky
Very steady
Not too volatile
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Soft
Weakest
Fair
Weakest
Fair
Weakest
Mild
Odds of Financial Distress
(Probability Of Bankruptcy)
Small
Low
Low
Low
Risky
Moderate
Low
Moderate
Low
Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Under Valued
Under Valued
Over Valued
Over Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Not Available
Not Available
Strong Buy
Not Available
Strong Buy
Not Available
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Hold
Cautious Hold
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Strong Hold
Sell
Hold
Current Ratio
1.22
5.32
0.1
2.38
6.24
N/A
2.21
N/A
8.31
13.59
Net Asset
11.36 B
296.19 M
23.03 M
157.33 M
264.5 M
77.51 M
210 M
34.94 M
119.17 M
280.73 M
Profit Margin
N/A
-0.0731
-0.75
-0.3
-0.68
N/A
N/A
N/A
-1.04
-1.07
EBITDA
(870.23 M)
(21.51 M)
(31.95 M)
(22.02 M)
(66.71 M)
(22.65 M)
(45.01 M)
(35.91 M)
(45.29 M)
(70.78 M)
Current Valuation
219.75 M
49.55 M
49.31 M
230.53 M
(5.62 M)
137.65 M
111.77 M
370.06 M
191.88 M
273.14 M
Operating Margin
N/A
-0.0698
-0.54
-0.0963
-0.61
N/A
-4.13
N/A
-1.01
-0.6
Price To Book
N/A
0.79
N/A
23.55
0.49
2.16
0.95
7.3
2.31
3.17
Retained Earnings
(754.8 M)
(152.84 M)
(96.98 M)
(369.51 M)
(1.17 B)
(58.33 M)
(373.75 M)
(131 M)
(825.92 M)
(404.93 M)
Current Asset
63.54 B
114.84 M
1.04 M
N/A
N/A
N/A
N/A
N/A
68.37 M
241.79 M
Beta
2.23
1.79
0.67
-562400.0
2.08
N/A
1.36
1.5
1.15
0.99
Number Of Employees
300
766
40
312
310
33
165
33
73
120
Shares Outstanding
14 M
27.15 M
548.74 M
51.36 M
18.31 M
21.77 M
65.38 M
50.65 M
15.82 M
29.02 M
Cash Flow From Operations
79.76 M
5.91 M
(12.72 M)
(18.53 M)
(46.33 M)
(18.09 M)
(36.6 M)
(29.99 M)
(51.12 M)
(19.27 M)
Total Debt
4.32 B
19.41 M
875 K
60.06 M
104.52 M
779 K
7.45 M
71.86 K
3.09 M
201.06 M
Return On Equity
N/A
-0.13
N/A
-7.2
-1.06
-0.48
-0.35
-0.61
-0.37
-0.6
Z Score
N/A
N/A
7.3
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Book Value Per Share
19.05
7.26
-0.06
-0.16
6.99
5.63
2.4
1.15
11.55
4.36
Return On Asset
N/A
-0.0621
-0.26
-0.0552
-0.15
-0.31
-0.2
-0.36
-0.16
-0.13
Number Of Shares Shorted
N/A
818.45 K
N/A
29.23 K
2.27 M
1.77 M
8.74 M
1.47 M
1.54 M
2.26 M
Current Liabilities
51.26 B
22.01 M
1.39 M
N/A
N/A
N/A
N/A
N/A
3.4 M
9.57 M
Total Asset
11.36 B
296.19 M
23.03 M
157.33 M
264.5 M
77.51 M
210 M
34.94 M
119.17 M
280.73 M
Debt To Equity
0.79
0.07
N/A
0.48
0.13
N/A
0.019
N/A
0.041
0.077
Target Price
19.6
13.0
0.34
7.4
10.5
32.64
7.4
14.4
47.75
20.25
Short Ratio
N/A
3.86
N/A
0.19
1.38
10.03
7.91
9.07
14.16
8.62
Shares Owned By Institutions
N/A
72.63
5.85
47.67
97.28
60.44
20.27
36.45
59.72
88.4
Market Capitalization
296.05 M
154.47 M
24.09 M
174.64 M
59.51 M
263.46 M
150.38 M
421.68 M
440.03 M
403.08 M
Price To Earning
16.52
61.63
-3.33
N/A
N/A
N/A
N/A
N/A
-10.58
366.13
Price To Earnings To Growth
0.0449
3.48
N/A
N/A
0.06
N/A
N/A
N/A
N/A
N/A
Price To Sales
6.51
0.45
1.06
1.69
0.5
N/A
12.22
N/A
11.83
6.02
Net Income
(937.91 M)
(35.89 M)
(30.94 M)
(24.72 M)
(81.65 M)
(20.59 M)
(53.52 M)
(25.74 M)
(40.18 M)
(81.89 M)
Earnings Per Share
-1.91
-1.0
-0.051
-0.52
-5.37
-2.53
-0.88
-0.88
-4.6
-3.21
Shares Owned By Insiders
N/A
12.15
7.09
11.6
2.7
14.55
0.21
16.37
32.29
4.69
Revenue
N/A
335.7 M
4.06 M
90.05 M
119.48 M
N/A
11.28 M
N/A
28.52 M
65.32 M
Working Capital
12.28 B
108.77 M
(356 K)
24.23 M
213.25 M
69.21 M
64.71 M
31.33 M
67.7 M
155.78 M
Cash And Equivalents
2.04 B
223.62 M
1.48 M
40.02 M
227.52 M
N/A
86.63 M
N/A
116.69 M
253.29 M
Cash Per Share
64.47
9.78
N/A
2.57
4.71
N/A
1.66
N/A
2.41
12.22
Gross Profit
N/A
155.32 M
8.02 M
66.46 M
46.75 M
N/A
(12.06 M)
N/A
(24.65 M)
66.98 M
Day Typical Price
13.03
5.79
24.31
3.49
3.38
12.65
2.33
8.18
28.53
13.97
Accumulation Distribution
366.63
3960.9
0.0586
0.0476
35949.49
1727.16
54338.27
1700.16
2925.73
3513.46
Market Facilitation Index
0.0
0.0
1.48
0.17
0.0
0.0
N/A
0.0
0.0
0.0
Daily Balance Of Power
(0.04)
1.0
(0.66)
0.6471
0.5641
0.5
0.25
(0.41)
0.9145
0.0811
Period Momentum Indicator
(0.01)
0.14
(0.97)
0.11
0.22
0.2
0.04
(0.07)
1.07
0.03
Rate Of Daily Change
1.0
1.02
0.96
1.03
1.07
1.02
1.02
0.99
1.04
1.0
Day Median Price
13.02
5.77
24.51
3.49
3.34
12.65
2.32
8.2
28.35
14.01
Price Action Indicator
0.025
0.13
(1.07)
0.08
0.25
0.1
0.04
(0.07)
1.08
(0.10)
Relative Strength Index
46.97
30.32
30.46
50.99
52.18
33.76
47.46
57.01
30.68
38.12
Coefficient Of Variation
(2,594)
(1,075)
(436.67)
1333.79
(1,243)
887.17
(2,556)
1031.46
(1,478)
1116.72
Mean Deviation
2.53
1.91
1.84
2.88
4.62
3.6
4.0
2.8
2.88
2.47
Jensen Alpha
(0.18)
(0.29)
(0.59)
0.2319
(0.60)
0.537
(0.30)
0.3736
(0.30)
0.2535
Total Risk Alpha
(0.33)
(0.40)
(0.68)
0.0938
(0.81)
0.3652
(0.52)
0.2001
(0.44)
0.1243
Sortino Ratio
N/A
N/A
N/A
0.0691
N/A
0.1387
N/A
0.1261
N/A
0.074
Downside Variance
N/A
N/A
N/A
10.58
N/A
18.11
N/A
7.95
N/A
9.78
Standard Deviation
3.73
2.77
2.44
3.62
6.34
5.65
5.94
4.15
3.78
3.11
Kurtosis
3.19
4.43
1.17
(0.0003)
2.1
9.91
6.09
7.2
0.5416
0.0565
Potential Upside
6.14
4.4
3.73
6.96
9.51
9.35
9.44
6.71
5.85
5.67
Treynor Ratio
(0.23)
(0.37)
(0.93)
0.3237
(0.23)
0.2556
(0.15)
0.7692
(0.26)
0.672
Maximum Drawdown
20.62
19.47
12.41
17.05
38.45
38.95
36.87
24.61
18.53
15.79
Variance
13.9
7.67
5.98
13.11
40.23
31.93
35.26
17.22
14.25
9.65
Market Risk Adjusted Performance
(0.22)
(0.36)
(0.92)
0.3337
(0.22)
0.2656
(0.14)
0.7792
(0.25)
0.682
Risk Adjusted Performance
(0.02)
(0.07)
(0.17)
0.0672
(0.05)
0.0978
(0.02)
0.0848
(0.05)
0.0783
Skewness
1.06
(0.46)
(0.35)
0.1381
0.5731
2.16
1.89
2.09
(0.32)
0.0058
Semi Deviation
N/A
N/A
N/A
3.1
N/A
3.69
N/A
2.55
N/A
2.69
Information Ratio
(0.05)
(0.11)
(0.25)
0.0621
(0.09)
0.1045
(0.05)
0.0857
(0.08)
0.0745
Value At Risk
(6.04)
(3.26)
(4.26)
(4.56)
(10.79)
(6.45)
(6.31)
(4.46)
(6.65)
(3.78)
Expected Short fall
N/A
N/A
N/A
(3.47)
N/A
(3.96)
N/A
(3.46)
N/A
(2.58)
Downside Deviation
N/A
N/A
N/A
3.25
N/A
4.26
N/A
2.82
N/A
3.13
Semi Variance
N/A
N/A
N/A
9.63
N/A
13.64
N/A
6.5
N/A
7.26

Shoulder Innovations Competition Performance Charts

Five steps to successful analysis of Shoulder Innovations Competition

Shoulder Innovations' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Shoulder Innovations in relation to its competition. Shoulder Innovations' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Shoulder Innovations in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Shoulder Innovations' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Shoulder Innovations, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Shoulder Innovations position

In addition to having Shoulder Innovations in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Funds Thematic Idea Now

Healthcare Funds
Healthcare Funds Theme
Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations. The Healthcare Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Funds Theme or any other thematic opportunities.
View All  Next Launch
How To Invest In Shoulder
Details
Is Shoulder Stock a good investment?
Details
What is Shoulder Innovations' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Shoulder Innovations Correlation with its peers.
For more detail on how to invest in Shoulder Stock please use our How to Invest in Shoulder Innovations guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is there potential for Health Care Equipment & Supplies market expansion? Will Shoulder introduce new products? Factors like these will boost the valuation of Shoulder Innovations. If investors know Shoulder will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Shoulder Innovations listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.91)
Shoulder Innovations's market price often diverges from its book value, the accounting figure shown on Shoulder's balance sheet. Smart investors calculate Shoulder Innovations' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Shoulder Innovations' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Shoulder Innovations' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shoulder Innovations is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shoulder Innovations' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY